Evidence map›Paper›PMID 37662484›Full record

ArticleKinases and phosphatases2023

Phosphorylation of Ack1 by the Receptor Tyrosine Kinase Mer.

Samantha Y Hayashi, Barbara P Craddock, W Todd Miller

Open access · diamondAbstract read
In one paragraph

Article in Kinases and phosphatases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Samantha Y HayashiDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0003-2885-4078
Barbara P CraddockDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.
W Todd MillerDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.
Stony Brook University · USNorthport VA Medical Center · US

Funding

Nonreceptor tyrosine kinases in Systemic Lupus ErythematosusR01AI164424 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI MILLER, W TODD · 2021 to 2025
$1.6M
NIAID NIH HHS R01 AI164424
6 · The paper itself

Abstract

Ack1 is a nonreceptor tyrosine kinase that is associated with cellular proliferation and survival. The receptor tyrosine kinase Mer, a member of the TAM family of receptors, has previously been reported to be an upstream activator of Ack1 kinase. The mechanism linking the two kinases, however, has not been investigated. We confirmed that Ack1 and Mer interact by co-immunoprecipitation experiments and found that Mer expression led to increased Ack1 activity. The effect on Ack1 was dependent on the kinase activity of Mer, whereas mutation of the Mer C-terminal tyrosines Y867 and Y924 did not significantly decrease the ability of Mer to activate Ack1. Ack1 possesses a Mig6 Homology Region (MHR) that contains adjacent regulatory tyrosines (Y859 and Y860). Using synthetic peptides, we showed that Mer preferentially binds and phosphorylates the MHR sequence containing phosphorylated pY860, as compared to the pY859 sequence. This suggested the possibility of sequential phosphorylation within the MHR of Ack1, as has been observed previously for other kinases. In cells co-expressing Mer and Ack1 MHR mutants, the Y859F mutant had higher activity than the Y860F mutant, consistent with this model. The interaction between Mer and Ack1 could play a role in immune cell signaling in normal physiology and could also contribute to the hyperactivation of Ack1 in prostate cancer and other tumors.

Indexed as

Ack1autoinhibitionMerMHRphosphorylationtyrosine kinase

Identifiers

PMID37662484
PMCPMC10473914
OpenAlexW4383737166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.